Benjamin Fryer

Chief Executive Officer at Pluristyx.

Raised on Pluristyx filings

$9.8M

of $14.8M offered across 1 Form D filing

Company

Biotech · Seattle, WA

Stem cell lines and manufacturing for cell therapy makers

Stem cell lines and manufacturing for cell therapy makers

Pluristyx Form D filings
Filed	Security	Sold of offered	Filing
Jul 13, 2026	Equity	$9.8M/ $14.8M	Form D

Also named on Pluristyx filings